Last update 08 May 2025

Nippon Shinya Co., Ltd. Beijing Representative Office

Dissolved
| Private Company|2011|Beijing Shi, China

Overview

Related

1
Drugs associated with Nippon Shinya Co., Ltd. Beijing Representative Office
NS-126Z
Target-
Mechanism-
Active Org.-
Originator Org.-
Active Indication-
Inactive Indication
Rhinitis, Allergic, Seasonal
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Nippon Shinya Co., Ltd. Beijing Representative Office
CTR20201737
/ CompletedPhase 3
NS-126Z治疗季节性变应性鼻炎的随机、双盲、安慰剂对照III期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase III clinical trial of NS-126Z in the treatment of seasonal allergic rhinitis
100 Clinical Results associated with Nippon Shinya Co., Ltd. Beijing Representative Office
Login to view more data
0 Patents (Medical) associated with Nippon Shinya Co., Ltd. Beijing Representative Office
Login to view more data
100 Deals associated with Nippon Shinya Co., Ltd. Beijing Representative Office
Login to view more data
100 Translational Medicine associated with Nippon Shinya Co., Ltd. Beijing Representative Office
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NS-126Z
Rhinitis, Allergic, Seasonal
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free